RPI
ALXN

Railway Pension Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Railway Pension Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-339,693
Closed -$62.4M – 251
2021
Q2 		$62.4M Buy
339,693
+600
+0.2% +$103K 0.52% 54
2021
Q1 		$51.9M Buy
339,093
+71,693
+27% +$11.1M 0.48% 63
2020
Q4 		$41.8M Buy
267,400
+52,100
+24% +$6.69M 0.4% 67
2020
Q3 		$24.6M Buy
215,300
+26,300
+14% +$2.84M 0.25% 96
2020
Q2 		$21.2M Buy
189,000
+61,000
+48% +$6.48M 0.24% 103
2020
Q1 		$11.5M Buy
+128,000
New +$12.6M 0.16% 136
2019
Q4 		– Sell
-20,700
Closed -$2.03M – 376
2019
Q3 		$2.03M Sell
20,700
-1,600
-7% -$180K 0.02% 330
2019
Q2 		$2.92M Buy
+22,300
New +$2.87M 0.04% 300

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Railway Pension Investments's ALXN Position: Q3 2021 in Review

Railway Pension Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 339,693 shares — an estimated $62.4M sold.

Railway Pension Investments first reported a position in ALXN in Q2 2019 and held it in 8 quarters. The position peaked at $62.4M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Railway Pension Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Railway Pension Investments sold 339,693 Alexion Pharmaceuticals shares in Q3 2021, an estimated $62.4M.
  • Railway Pension Investments first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 8 quarters.
  • Railway Pension Investments's Alexion Pharmaceuticals position peaked at $62.4M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Railway Pension Investments's 13F filing for Q3 2021, filed 26 Oct 2021.